(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15.99%3.74B | 23.85%7.25B | 26.36%3.23B | 27.56%5.86B | 23.58%2.55B | 16.26%4.59B | 22.39%2.07B | 8.02%3.95B | -12.28%1.69B | 9.44%3.66B |
Operating income | 15.99%3.74B | 23.85%7.25B | 26.36%3.23B | 27.56%5.86B | 23.58%2.55B | 16.26%4.59B | 22.39%2.07B | 8.02%3.95B | -12.28%1.69B | 9.44%3.66B |
Cost of sales | -17.81%-2.41B | -18.97%-4.67B | -21.61%-2.05B | -26.99%-3.93B | -21.43%-1.68B | -14.43%-3.09B | -21.17%-1.39B | -7.74%-2.7B | 14.72%-1.15B | -6.77%-2.51B |
Operating expenses | -17.81%-2.41B | -18.97%-4.67B | -21.61%-2.05B | -26.99%-3.93B | -21.43%-1.68B | -14.43%-3.09B | -21.17%-1.39B | -7.74%-2.7B | 14.72%-1.15B | -6.77%-2.51B |
Gross profit | 12.83%1.33B | 33.77%2.58B | 35.58%1.18B | 28.72%1.93B | 27.97%867.93M | 20.23%1.5B | 24.97%678.21M | 8.62%1.25B | -6.64%542.69M | 15.77%1.15B |
Selling expenses | -6.06%-309.32M | -26.63%-649.48M | -26.54%-291.63M | -17.18%-512.91M | -23.48%-230.47M | -21.37%-437.71M | -25.43%-186.65M | -9.51%-360.64M | 1.88%-148.81M | -12.45%-329.32M |
Administrative expenses | -15.19%-173.1M | -51.80%-327.36M | -31.80%-150.28M | -21.56%-215.65M | -33.03%-114.02M | -4.80%-177.41M | -0.43%-85.71M | 5.74%-169.28M | -0.49%-85.34M | -2.91%-179.6M |
Research and development expenses | -1.17%-308.19M | -18.00%-681.38M | -23.17%-304.63M | -36.04%-577.44M | -34.77%-247.33M | -26.73%-424.48M | -44.54%-183.52M | -36.31%-334.94M | -9.53%-126.97M | -12.89%-245.72M |
Impairment and provision | -47.70%-55.33M | 21.95%-73.52M | -13.56%-37.46M | -35.35%-94.19M | -18.11%-32.99M | -24.52%-69.59M | -101.39%-27.93M | -122.50%-55.89M | -64.97%-13.87M | -213.07%-25.12M |
-Other impairment is provision | -47.70%-55.33M | 21.95%-73.52M | -13.56%-37.46M | -35.35%-94.19M | -18.11%-32.99M | -24.52%-69.59M | -101.39%-27.93M | -122.50%-55.89M | -64.97%-13.87M | -213.07%-25.12M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---99.27M | ---- | ---- | ---- | ---86.52M |
Special items of operating profit | 238.98%141.21M | -12.41%142.48M | -52.56%41.66M | -10.82%162.68M | 1.12%87.82M | 9.66%182.41M | -4.86%86.85M | 21.33%166.35M | 47.46%91.29M | 12.85%137.11M |
Operating profit | 43.42%623.01M | 43.34%991.51M | 31.25%434.39M | 46.32%691.7M | 17.67%330.95M | -3.95%472.73M | 8.60%281.25M | 17.61%492.17M | 6.03%258.99M | -0.30%418.47M |
Financing cost | -0.44%-62.69M | -16.92%-131.53M | -20.40%-62.42M | ---112.5M | -6.69%-51.84M | ---- | 1.70%-48.59M | ---96.26M | ---49.43M | ---- |
Share of profits of associates | --296K | -76.63%756K | ---- | --3.24M | ---- | ---- | ---- | ---- | ---- | 128.97%168K |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4M |
Earning before tax | 50.71%560.62M | 47.78%860.73M | 33.27%371.97M | 23.21%582.43M | 19.97%279.11M | 19.40%472.73M | 11.02%232.66M | -4.52%395.91M | -12.84%209.56M | 15.32%414.63M |
Tax | -67.07%-94.94M | -40.50%-100.14M | -36.46%-56.83M | -59.24%-71.27M | -31.19%-41.65M | 13.50%-44.76M | 10.99%-31.74M | 9.63%-51.74M | -24.94%-35.66M | -98.98%-57.26M |
After-tax profit from continuing operations | 47.77%465.67M | 48.80%760.59M | 32.71%315.14M | 19.44%511.16M | 18.19%237.47M | 24.35%427.97M | 15.54%200.92M | -3.70%344.17M | -17.93%173.89M | 8.04%357.38M |
Earning after tax | 47.77%465.67M | 48.80%760.59M | 32.71%315.14M | 19.44%511.16M | 18.19%237.47M | 24.35%427.97M | 15.54%200.92M | -3.70%344.17M | -17.93%173.89M | 8.04%357.38M |
Minority profit | 32.88%134.64M | 27.75%239.36M | 7.62%101.33M | 17.18%187.36M | 21.05%94.15M | 41.52%159.89M | 34.96%77.78M | 47.09%112.98M | 38.54%57.63M | 28.12%76.81M |
Profit attributable to shareholders | 54.82%331.03M | 60.98%521.23M | 49.19%213.82M | 20.78%323.8M | 16.38%143.32M | 15.96%268.08M | 5.91%123.14M | -17.60%231.19M | -31.73%116.26M | 3.60%280.57M |
Basic earnings per share | 54.38%0.335 | 60.18%0.527 | 48.63%0.217 | 20.96%0.329 | 16.80%0.146 | 15.74%0.272 | 5.93%0.125 | -17.25%0.235 | -30.59%0.118 | 5.19%0.284 |
Diluted earnings per share | 53.92%0.334 | 60.18%0.527 | 48.63%0.217 | 20.96%0.329 | 16.80%0.146 | 15.74%0.272 | 5.93%0.125 | -17.25%0.235 | -30.59%0.118 | 5.19%0.284 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data